Litcius/Paper detail

Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis

João Paulo Fernandes Felix, Rodrigo Pessoa Cavalcanti Lira, Alex Treiger Grupenmacher, Hermano Lucio Gomes de Assis Filho, Alexandre Brito Cosimo, Maurício Abujamra Nascimento, Carlos Eduardo Leite Arieta

2020American Journal of Ophthalmology37 citationsDOI

Topics & Concepts

MedicineTrimethoprimPlaceboSulfamethoxazoleCohortSurgeryToxoplasma gondiiInternal medicineToxoplasmosisGastroenterologyAntibioticsImmunologyAntibodyPathologyMicrobiologyAlternative medicineBiologyToxoplasma gondii Research StudiesPneumocystis jirovecii pneumonia detection and treatmentLeptospirosis research and findings
Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis | Litcius